CEBP Frontiers in Cancer Prevention Research - 2008 Cancer Health Disparities Conference 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Eder, E.
Right arrow Articles by Budiawan,
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Eder, E.
Right arrow Articles by Budiawan,
Cancer Epidemiology Biomarkers & Prevention Vol. 10, 883-888, August 2001
© 2001 American Association for Cancer Research

Cancer Risk Assessment for the Environmental Mutagen and Carcinogen Crotonaldehyde on the Basis of TD50 and Comparison with 1,N2-Propanodeoxyguanosine Adduct Levels1

Erwin Eder2 and Budiawan

Department of Toxicology, University of Würzburg, 97078 Würzburg, Germany [E. E.], and Department of Chemistry, Faculty of Mathematic and Science, University of Indonesia, Jakarta, Indonesia [B.]

Humans are ubiquitously exposed to crotonaldehyde to a strongly varying extent, in particular, via food and alcoholic beverages. Like other {alpha},ß-unsaturated carbonyl compounds, crotonaldehyde forms 1,N2-propanodeoxyguanosine adducts and is genotoxic, mutagenic, and carcinogenic. This study was designed to perform a cancer risk assessment on the basis of TD50, which was available from a long-term cancer study with F-344 rats (F. L. Chung et al., Cancer Res., 46: 1285–1289, 1986), and the estimated daily intake via food and beverages. A relatively high cancer risk of 0.1–1 cancer incidence/103 humans was extrapolated on the basis of the TD50 from the cancer study of Chung et al. for the estimated dietary intake and drinking wine. To compare the 1,N2-propanodeoxyguanosine DNA adduct levels of crotonaldehyde with the assessed cancer risk, we synthesized adduct standards and developed a 32P-postlabeling method for DNA adducts of crotonaldehyde providing a detection limit of 3 adducts/109 nucleotides. Repeated gavages of 10 and 1 mg/kg were given to simulate the steady-state situation of the animal cancer study of Chung et al. and to estimate the adduct levels after intake of crotonaldehyde via food. The estimated adduct levels at these crotonaldehyde intakes were in the range of 3 adducts/109 nucleotides. The adducts persisted to a certain extent. The persistence is important for considering the steady-state situation after permanent intakes of crotonaldehyde via food. However, the adducts are repaired to some extent; 2 weeks after the last of repeated gavages, only 19% of the initial amount measured directly after the last gavage is left. According to our results, a steady-state concentration in the range of 3 adducts/109 nucleotides is responsible for the induction of cancer in the study of Chung et al., in the case that cancer from crotonaldehyde depends exclusively on the 1,N2-propanodeoxyguanosine adducts considered here. No propanodeoxyguanosine adducts of crotonaldehyde were found in the DNA of untreated animals in our studies.




This article has been cited by other articles:


Home page
Hum Exp ToxicolHome page
G Scherer, M Urban, H-W Hagedorn, S Feng, R D Kinser, M Sarkar, Q Liang, and H-J Roethig
Determination of two mercapturic acids related to crotonaldehyde in human urine: influence of smoking
Human and Experimental Toxicology, January 1, 2007; 26(1): 37 - 47.
[Abstract] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
Z. Feng, W. Hu, Y. Hu, and M.-s. Tang
From the Cover: Acrolein is a major cigarette-related lung cancer agent: Preferential binding at p53 mutational hotspots and inhibition of DNA repair
PNAS, October 17, 2006; 103(42): 15404 - 15409.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2001 by the American Association for Cancer Research.